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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S228developed a novel method for isolating site-matched overlying AC and
underlying SB from regions of interest respectively from the human
knee tibial plateau. Thus, in this study we aimed to evaluate for the ﬁrst
time the differences in gene expression proﬁles of human normal and
osteoarthritic subchondral bone.
Methods: The severity of bone abnormality was ﬁrst determined by
microcomputed tomography. An optimized RNA extraction procedure
was also developed to extract high quality total RNA from regions of
interest from human OA (n ¼ 20) and non-OA (n ¼ 5) knee lateral (LT)
and medial tibial plateaus (MT). Whole-genome expression proﬁling
study was performed using the Agilent Whole Human Genome
Microarray 4x44K Kit with the data analyzed by Agilent GeneSpring
GX11.5. The expression of the 85 genes identiﬁed bymicroarray to show
differential expression was validated using quantitative reverse-tran-
scription polymerase chain reaction (qRT-PCR) analysis on nine OA.
Immunohistochemical staining was also performed to conﬁrm the
expression analysis ﬁndings. Ingenuity Pathway Analysis (IPA) was used
to investigate pathways analysis to determine whether new novel
pathway in OA could be identiﬁed.
Results: A total of 972 deferentially expressed genes with greater than
two fold change were identiﬁed between normal and damaged regions
from the subchondral bone isolated from OA knee joint tissues. The
qRT-PCR and Immunohistochemical data validated the accuracy of
microarray results with high degree (R2 ¼ 0.5764, P < 0.0001). Pathway
analysis showed that these genes were clustered in 279 canonical
pathways and several novel pathways were identiﬁed, including
phosphor-v-akt murine thymoma viral oncogene homolog 1 (p-AKT),
Periostin (POSTN), and Leptin (LEP), which implicated the involvement
of bone remodeling by osteoblasts.
Conclusions: To the best of our knowledge, this study represents the
ﬁrst and the most comprehensive direct assessment of gene expression
proﬁling conducted in OA subchondral bone. With the ability to directly
studying genetic proﬁles of subchondral bone could further the
understanding of the parthenogenesis of the disease.
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FUNCTIONAL ANALYSIS OF THE OSTEOARTHRITIS SUSCEPTIBILITY
LOCUS RESIDING AT THE CARBOHYDRATE SULFOTRANSFERASE 11
GENE CHST11
L.N. Reynard, M. Ratnayake, M. Santibanez-Koref, J. Loughlin. Newcastle
Univ., Newcastle upon Tyne, United Kingdom
Purpose: CHST11 encodes an enzyme that catalyses the transfer of
sulphate groups to chondroitin to form chondroitin-4-sulphate, a major
component of glycosaminoglycan (GAG) chains in the cartilage extrac-
ellular matrix. The single nucleotide polymorphism (SNP) rs835487
that is located within intron 2 of CHST11 is associated with hip OA, at
the genome-wide signiﬁcance level, with a p-value of 1.64x10-8. The
aim of this study was to 1) assess the role of CHST11 in cartilage
development and homeostasis, and 2) identify the causal allele or
alleles that account for the OA association signal and determine how
this acts to increase susceptibility to the disease.
Methods: The CHST11 open reading frame (ORF) was sequenced in 200
hip OA patients. CHST11 expression in normal and osteoarthritic carti-
lage was assessed using quantitative PCR. CHST11 protein was depleted
or overexpressed in human iliac crest derived mesenchymal stem cells
(MSCs) followed by chondrogenic differentiation using siRNAs and
lentivirus transduction, respectively. SNPs in linkage disequilibrium
(LD) with the association SNP rs835487 were identiﬁed and their
function tested using luciferase enhancer assays in the human chon-
drosarcoma cell line SW1353. Allelic differences in enhancer activity
were analysed further using electrophoretic mobility shift assays
(EMSAs) and transcription factor prediction tools to identify trans-act-
ing factors that bind to these functional SNPs.
Results: There are no common amino acid changes within CHST11,
indicating that the OA susceptibility has to be mediated by a cis-acting
regulatory polymorphism that inﬂuences CHST11 expression. CHST11 is
upregulated 2.6 fold in OA hip cartilage relative to non-OA hip cartilage
(p ¼ 0.007). CHST11 depletion caused a 27% reduction (p ¼ 0.005) and
CHST11 overexpression a 22% increase (p ¼ 0.015) in the wet weight of
cartilage discs formed by chondrogenic differentiation of MSCs.
Expression of SOX9, COL2A1 and ACAN were down-regulated and
RUNX2, MMP13 and ADAMTS5 up-regulated in cartilage discs formed
from CHST11 knock-down MSCs relative to the control non-targeting
siRNA. Micromass cultures of MSCs after CHST11 protein knock-downalso had reduced GAG sulfation as determined by quantiﬁcation of
Alcian Blue staining. We identiﬁed six candidate SNPs within the OA
association interval which is located within a region predicted to have
transcriptional enhancer activity. There was differential enhancer
activity of the two alleles of the rs835487 and rs835488 SNPs; these two
SNPs are in perfect LD and our data suggests that they have an additive
or synergistic effect on enhancer activity. EMSA supershift studies
demonstrated that the transcription factors SP1, SP3 and SUB1 bind to
both rs835487 and rs835488, with YY1 binding speciﬁcally over the
rs835488 SNP. These proteins bind more avidly to the OA-associated
alleles of rs835487 and rs835488 than the non-OA associated alleles.
Conclusions: CHST11 plays an important role in chondrogenesis, with
loss of the protein leading to decreased matrix synthesis and increased
chondrocyte hypertrophy. rs835487 and rs835488 are the top candi-
date SNPs for the OA susceptibility, with the disease associated GT
haplotype of the two SNPs having signiﬁcantly different enhancer
activity relative to the AC haplotype in-vitro. Furthermore, several
transcription factors bind more strongly to the disease-associated
alleles. We conclude that the OA susceptibility residing within CHST11
is mediated by differential protein binding to the alleles of the rs835487
and rs835488 SNPs, which are located within a region that functions as
a cis-acting enhancer of CHST11 transcription.
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ALLELIC EXPRESSION ANALYSIS OF GENES FROM WITHIN THE
OSTEOARTHRITIS SUSCEPTIBILITY LOCUS AT CHROMOSOME 3P21
REVEALS FUNCTIONAL GENE EXPRESSION EFFECTS AT GNL3 AND
SPCS1 THAT CORRELATE WITH THE ASSOCIATION SIGNAL
F.H. Gee, C.F. Clubbs, E.V. Raine, L.N. Reynard, J. Loughlin. Newcastle
Univ., Newcastle Upon Tyne, United Kingdom
Purpose: A genome-wide association scan with subsequent replication
study involving over 67,000 individuals of European ancestry produced
highly signiﬁcant evidence of an association of single nucleotide poly-
morphisms (SNPs) rs6976 and rs11177 to severe primary osteoarthritis
(OA), with p-values of 7.24  1011 and 1.25  1010, respectively. The
two SNPs are in perfect linkage disequilibrium (LD); rs6976 is located in
the 3’UTR of GLT8D1 and rs11177 is a non-synonymous SNP within exon
3 of GNL3. These two genes map to chromosome 3p21.1 and are part of
an association interval that encompasses ten other genes. The amino
acid substitution caused by rs11177 is benign and there are no other
amino acid substitutions within the twelve genes that can account for
the association signal. There is mounting evidence to suggest that most
common complex trait alleles are cis-acting regulatory polymorphisms
that inﬂuence, in a tissue-speciﬁc manner, gene transcription or tran-
script stability, resulting in allelic expression imbalance (AEI). We
therefore used allelic expression analysis to assess whether the OA
association at 3p21.1 is mediated by cis-acting regulatory poly-
morphisms that act on the genes from within the association interval.
Methods:We focused on those genes that are expressed in joint tissues.
We initially measured gene expression by quantitative PCR, using RNA
extracted from the hip cartilage of OA patients who had undergone
elective hip replacement surgery, and of non-OA patients who had
undergone surgery for a neck-of-femur (NOF) fracture. A two-tailed
Mann-Whitney exact test was used to determine whether gene
expression differed signiﬁcantly between the two groups. We then
assessed AEI using pyrosequencing assays that can accurately dis-
tinguish and quantify the mRNA synthesized from both alleles of a
transcript SNP. We used mRNA extracted from the cartilage, fat pad and
synovium of primary OA patients who had undergone elective joint
replacement surgery. DNA from the tissues was used to provide the 1:1
ratio to which the mRNA ratios were compared in the AEI analysis. For
each gene we studied at least 17 informative patients. A two-tailed
Mann-Whitney exact test was used to test the signiﬁcance of any allelic
expression differences.
Results: SPCS1, GLT8D1 and NT5DC2 demonstrated signiﬁcantly higher
expression in hip OA cartilage relative to NOF control cartilage (SPCS1, p
¼ 0.02; GLT8D1, p ¼ 0.02; NT5DC2, p ¼ 0.0005). GNL3 and SPCS1
demonstrated signiﬁcant AEI in OA cartilage (GNL3, mean AEI ¼ 1.04, p
¼ 0.0002; SPCS1, mean AEI ¼ 1.07, p < 0.0001) and in a direction that
correlated with the association signal. Similar AEI results were observed
for these two genes in fat pad and synovial tissue (GNL3, mean AEI ¼
1.04, p ¼ 0.01; SPCS1, mean AEI ¼ 1.09, p ¼ 0.01). For both genes,
expression of the OA-associated allele was lower than that of the non-
associated allele.
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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S229Conclusions: Our AEI results suggest that cis-acting regulatory poly-
morphisms acting on GNL3 and SPCS1 contribute to the OA association
signal at chromosome 3p21. The SNP used to study AEI for GNL3 was
rs11177whilst the one used for SPCS1 was rs6617. These two SNPs are in
high LD with each other (r2 ¼ 0.93), such that the minor alleles for both
SNPs are inherited together in a haplotype that correlates tightly with
the association signal. As both genes show reduced expression of the
OA-associated allele, it seems possible that they are co-ordinately
regulated. Functionally, although the association signal correlates with
only a small decrease in expression of each gene, an individual carrying
the associated allele will carry the shared haplotype and shall therefore
be subjected to the combined effect of a lower expression of both genes.
We hypothesise that this combined effect contributes to the increased
risk of developing OA that maps to this region of the genome. SPCS1
codes for signal peptidase complex subunit 1 homolog, a subunit of a
complex that acts to cleave signal sequences from secretory and
membrane proteins in the lumen of the endoplasmic reticulum. GNL3
codes for guanine nucleotide binding protein-like 3, also known as
nucleostemin. This protein is concentrated in stem cell nucleoli, and is
known tomodulate p53 function, thereby performing a role in cell cycle
regulation and cell proliferation and self-renewal. GNL3 also has a
broader role in maintenance of nucleolar structure and telomerase
activity. Our results now justify much more detailed investigation of
these two genes, and of their encoded proteins, in the context of OA
etiology.
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IS TYPE 2 DIABETES RELATED TO OSTEOARTHRITIS? A MENDELIAN
RANDOMISATION STUDY THAT INVESTIGATES GLYCEMIC TRAITS
AND OSTEOARTHRITIS
T.A. Hoeven, P.S. de Vries, A. Dehghan, O.H. Franco, A. Hofman,
P.J. Bindels, S.M. Bierma-Zeinstra, J.B. van Meurs. Erasmus Univ. Med.
Ctr., Rotterdam, Netherlands
Purpose: Previous studies examining the relationship between type 2
diabetes mellitus (DM) and osteoarthritis (OA) have presented con-
ﬂicting results that are further hampered bymethodological issues such
as reverse causality, measurement error or possible confounding by
lifestyle factors and baseline health status. Hence, it remains unclear
whether DM and OA are associated and/or causally related. One way to
address causation in epidemiology, particularly in chronic diseases, is
the use of mendelian randomization. The random assortment of alleles
at the time of gamete formation results in population distributions of
genetic variants that are generally independent of behavioral factors
that confound epidemiological associations. In other words, mendelian
randomization through genetic risk factors might overcome con-
founding and reverse causality, which hamper the interpretation of
classical epidemiological studies. We therefore investigated whether
genetically deﬁned elevated levels of glycemic traits (fasting glucose
and fasting insulin) were associated with the presence of OA of the
knee, hip and hand in a large population-based study.
Methods: In a population-based cohort study involving participants
aged 45 years and older (the Rotterdam Study), genotypes and cova-
riates were collected at baseline (n ¼ 10,213; mean age 66.0 years; 41%
men). We constructed weighted genetic risk scores based on single-
nucleotide polymorphisms (SNPs) known to be associated with fasting
insulin (n ¼ 11 SNPs) or fasting glucose (n ¼ 36 SNPs), independent of
body mass index. SNPs that were known to be associated with both
fasting insulin and fasting glucose levels were excluded. X-rays were
scored using the Kellgren–Lawrence score for OA at baseline and
osteoarthritis was deﬁned as a Kellgren–Lawrence score 2. We ana-
lysed the genetic risk scores for their association with presence of OA
using logistic regression analysis.
Results:Within the study population, 17% had radiographic knee OA, 8%
hip OA, and 29% hand OA. The genetic risk scores for fasting glucose and
fasting insulin levels were associated with fasting glucose levels and
fasting insulin levels in the population (p¼ 4.39 1030, and p¼ 1.77
105 respectively) and explained 0.9% and 0.4% of the total variance of
the glycemic traits. No signiﬁcant association was found between the
fasting insulin genetic risk and OA-prevalence. However, genetically
deﬁned higher glucose levels were associated with a lower risk for knee
OA. Unadjusted analyses showed similar results.*Adjusted for age, sex, body mass index, hypertension, cholesterol ratio,
and smoking. **p < 0.01
Conclusions: In this population-based cohort study persons with
increased genetic risk scores for glycemic traits were not at higher risk
of OA. These ﬁrst analyses using genetically deﬁned elevated levels of
fasting insulin and fasting glucose point in the direction of a non-causal
role for diabetes mellitus type 2 in the development of osteoarthritis.
The use of genetic risk scores might be a way to disentangle complex
associations prone to confounding.
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A GENOME WIDE ASSOCIATION STUDY OF PRESSURE PAIN
THRESHOLD IN THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT
Y. Liu y, A. Goode z, W. Maixner x, S. Smith x, J.M. Jordan y. y Thurston
Arthritis Res. Ctr., Univ. of North Carolina at Chapel Hill, Chapel Hill, NC,
USA; zCommunity and Family Med., Duke Univ., Durham, NC, USA;
xRegional Ctr. for Neurosensory Disorders, Dept. of Endodontics, Sch. of
Dentistry, Univ. of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Purpose: Pressure pain threshold (PPT) is a biological marker of indi-
vidual pain perception that has been found to be signiﬁcantly associated
with symptomatic knee and hip osteoarthritis (OA). Although p in is a
well-known heritable phenotype, previous studies to identify genes
associated with PPT have not been conducted. The purpose of these
analyses was to identify single nucleotide polymorphisms (SNPs) asso-
ciated with PPT among African Americans, Caucasians and Caucasian
Men and Women.
Methods: These analyses consist of 1,199 participants with complete
genome enrolled in the Johnston County Osteoarthritis (JoCo) Project
between 2003 and 2004. PPT measurements were averaged over three
trials from left and right trapezius muscles using a standard baseline
dolorimeter. Since over 63% of participants had PPT measures >4 kg we
created a dichotomous variable to represent participants with low PPT
(<4kg), as the referent, and high PPT (4 kg), as the index. Genome
wide genotyping was conducted among all participants using the Illu-
mina Inﬁnium 1M-Duo array. Single marker analysis was performed
using logistic regression adjusting for sex, race, age, body mass index
(BMI) and Center for Epidemiologic Studies Depression (CES-D) Scale
score. Genome wide association (GWAS) analysis was conducted in
Caucasians and African Americans separately. Sex speciﬁc GWAS anal-
ysis was performed in Caucasians to investigate the genetic difference
between men and women. GWAS statistical signiﬁcance was set at
10e-8.
Results: Participants, mean age was 68.1 (SD 9.0), 63.0% female,
36.4% African American, mean body mass index (BMI) 31.2 Kg/m2
(SD ¼ 7.0 Kg/m2) and a mean Center for Epidemiologic Studies
Depression (CES-D) Scale score of 6.5 (SD 7.4). Sex, age, BMI and
CES-D scale were all statistically signiﬁcantly associated with PPT (p
< 0.01). GWAS analysis results indicated no SNP reached a 10e-8
signiﬁcance level. Six SNPs had p-values less than 10e-7. Among
these six SNPs, ﬁve are located in the coding regions of three genes
(PLD5, ZNF253 and ZNF93). PLD5 (Phospholipase D Family, Member
5) had been reported to be associated with multiple sclerosis.
ZNF253 and ZNF93 both belong to Zinc Finger Protein family and
may be involved in transcriptional regulation. All the six SNPs are
also signiﬁcant in sex speciﬁc analysis. In addition, rs11916152
(located in MGLL gene) was associated with PPT in men only (p ¼
9.83e-6) and rs6967902 (located in DYNC1I1 gene) in women only
(p ¼ 4.71e-6). MGLL gene plays a critical role in several physiological
processes including pain while the DYNC1I1 gene is related with the
